Gainers Calliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...
网页链接Gainers Calliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...
网页链接
精彩评论